Eileen White is the Associate Director of the Ludwig Institute Cancer Research at the Princeton Branch and serves as the Deputy Director and Chief Scientific Officer of the Rutgers Cancer Institute of New Jersey (RCI). She was born in Long Island, New York and earned her B.S. in Biology from Rensselaer Polytechnic Institute in 1977, followed by a Ph.D. in Biology from SUNY Stony Brook in 1983. White's career includes a postdoctoral fellowship at Damon Runyon and a role as a staff investigator at Cold Spring Harbor Laboratory before her contributions to RCI. She is an elected member of the National Academy of Sciences and a fellow of the American Association for the Advancement of Science, as well as the American Academy of Microbiology. White is a prominent cancer biologist recognized for her research on the functions of DNA tumor virus oncogenes and their ability to inhibit apoptosis through mechanisms similar to the human BCL-2 oncogene. Her laboratory specializes in identifying the mechanisms that allow tumor cells to survive and thrive within the hostile tumor microenvironment, aiming to uncover new therapeutic strategies. Notably, she has studied how tumor cells utilize autophagy to cope with nutrient deprivation and how these processes contribute to tumor growth and immune evasion.